These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 10486432)

  • 1. Influence of non-ionic surfactants, pH and propylene glycol on percutaneous absorption of piroxicam from cataplasm.
    Okuyama H; Ikeda Y; Kasai S; Imamori K; Takayama K; Nagai T
    Int J Pharm; 1999 Sep; 186(2):141-8. PubMed ID: 10486432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of nonionic surfactants on the percutaneous absorption tenoxicam.
    Endo M; Yamamoto T; Ijuin T
    Chem Pharm Bull (Tokyo); 1996 Apr; 44(4):865-7. PubMed ID: 8681419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced efficacy by percutaneous absorption of piroxicam from the poloxamer gel in rats.
    Shin S; Cho C; Oh I
    Int J Pharm; 2000 Jan; 193(2):213-8. PubMed ID: 10606784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of piroxicam: hydroxypropyl-beta-cyclodextrin complexation on the in vitro permeation and skin retention of piroxicam.
    Doliwa A; Santoyo S; Ygartua P
    Skin Pharmacol Appl Skin Physiol; 2001; 14(2):97-107. PubMed ID: 11316968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancing effect of polyoxyethylene alkyl ethers on the skin permeation of ibuprofen.
    Park ES; Chang SY; Hahn M; Chi SC
    Int J Pharm; 2000 Nov; 209(1-2):109-19. PubMed ID: 11084251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transdermal lontophoresis and skin retention of piroxicam from gels containing piroxicam: hydroxypropyl-beta-cyclodextrin complexes.
    Doliwa A; Santoyo S; Ygartua P
    Drug Dev Ind Pharm; 2001 Sep; 27(8):751-8. PubMed ID: 11699826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of various combinations of mucolytic agent and non-ionic surfactant on intestinal absorption of poorly absorbed hydrophilic compounds.
    Takatsuka S; Morita T; Horikiri Y; Yamahara H; Saji H
    Int J Pharm; 2008 Feb; 349(1-2):94-100. PubMed ID: 17869034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined effect of oleic acid and propylene glycol on the percutaneous penetration of tenoxicam and its retention in the skin.
    Larrucea E; Arellano A; Santoyo S; Ygartua P
    Eur J Pharm Biopharm; 2001 Sep; 52(2):113-9. PubMed ID: 11522475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of propylene glycol on ibuprofen absorption into human skin in vivo.
    Herkenne C; Naik A; Kalia YN; Hadgraft J; Guy RH
    J Pharm Sci; 2008 Jan; 97(1):185-97. PubMed ID: 17497726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of vehicles and penetration enhancers on the in vitro percutaneous absorption of tenoxicam through hairless mouse skin.
    Gwak HS; Chun IK
    Int J Pharm; 2002 Apr; 236(1-2):57-64. PubMed ID: 11891070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of penetration enhancement of lidocaine by nonionic surfactants through hairless mouse skin in vitro.
    Sarpotdar PP; Zatz JL
    J Pharm Sci; 1986 Feb; 75(2):176-81. PubMed ID: 3958929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel transdermal patch incorporating meloxicam: in vitro and in vivo characterization.
    Ah YC; Choi JK; Choi YK; Ki HM; Bae JH
    Int J Pharm; 2010 Jan; 385(1-2):12-9. PubMed ID: 19833177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Micellar solubilization of timobesone acetate in aqueous and aqueous propylene glycol solutions of nonionic surfactants.
    Ong JT; Manoukian E
    Pharm Res; 1988 Nov; 5(11):704-8. PubMed ID: 3247274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissolution of ionizable water-insoluble drugs: the combined effect of pH and surfactant.
    Jinno J; Oh Dm; Crison JR; Amidon GL
    J Pharm Sci; 2000 Feb; 89(2):268-74. PubMed ID: 10688756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of formulated tenoxicam transdermal delivery systems.
    Kim T; Kang E; Chun I; Gwak H
    J Pharm Pharmacol; 2008 Jan; 60(1):135-8. PubMed ID: 18088513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced bioavailability of piroxicam via salt formation with ethanolamines.
    Gwak HS; Choi JS; Choi HK
    Int J Pharm; 2005 Jun; 297(1-2):156-61. PubMed ID: 15907602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biowaiver monographs for immediate release solid oral dosage forms: piroxicam.
    Shohin IE; Kulinich JI; Ramenskaya GV; Abrahamsson B; Kopp S; Langguth P; Polli JE; Shah VP; Groot DW; Barends DM; Dressman JB
    J Pharm Sci; 2014 Feb; 103(2):367-77. PubMed ID: 24301077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of skin pretreatment with fatty acids on percutaneous absorption and skin retention of piroxicam after its topical application.
    Santoyo S; Ygartua P
    Eur J Pharm Biopharm; 2000 Sep; 50(2):245-50. PubMed ID: 10962234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Permeation of piroxicam from the poloxamer gels.
    Shin SC; Cho CW; Choi HK
    Drug Dev Ind Pharm; 1999 Mar; 25(3):273-8. PubMed ID: 10071819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of formulation excipients on the penetration and lateral diffusion of ibuprofen on and within the stratum corneum following topical application to humans.
    Gee CM; Watkinson AC; Nicolazzo JA; Finnin BC
    J Pharm Sci; 2014 Mar; 103(3):909-19. PubMed ID: 24421242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.